Last Andrew J. 4

What Happened
Andrew J. Last, a director of Insight Molecular Diagnostics, was granted 26,943 restricted stock units (RSUs) on 2026-06-11. The grant was recorded at $0.00 cash consideration (i.e., no purchase price paid). This is an equity award (not a market buy or sale) and represents compensation rather than an immediate cash transaction.

Key Details

• Transaction type: Award / grant of Restricted Stock Units (Code A)
• Transaction date: 2026-06-11; Form 4 filed 2026-06-15 (filed within the SEC’s two-business-day deadline)
• Shares granted: 26,943 RSUs; price recorded: $0.00 (no cash paid)
• Shares owned after transaction: Not reported in the provided filing summary
• Footnote: RSUs vest on the date of the next annual shareholders’ meeting, subject to the reporting person’s continued service from grant to vesting (see F1)

Context
RSU grants to directors are common as part of compensation packages and do not represent immediate cash proceeds. The economic value to the insider depends on future vesting and the company’s share price at that time; unvested RSUs can be forfeited if service conditions aren’t met. This filing simply documents the grant and its vesting condition and was timely filed.